$MDNAF #OTCQB Medicenna Therapeutics Corp. (MDNAF: OTCQB) | Medicenna Announces Presentation of the MDNA55 Clinical Trial at the Inaugural Glioblastoma Drug Development Annual Summit
Copyright 2019 – OTC Markets Group Inc.

News Link